Two Sigma Investments
ADIL

Two Sigma Investments’s Adial Pharmaceuticals ADIL Stock Holding History

Two Sigma Investments’s Portfolio ADIL Stock Details ADIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-432
Closed -$3.26K – 3633
2025
Q2 		$3.26K Buy
+432
New +$6.52K ﹤0.01% 3148
2023
Q3 		– Sell
-28
Closed -$3.67K – 2933
2023
Q2 		$3.67K Hold
28
– – ﹤0.01% 2962
2023
Q1 		$6.2K Sell
28
-65
-70% -$15.8K ﹤0.01% 2907
2022
Q4 		$12.6K Hold
93
– – ﹤0.01% 2718
2022
Q3 		$20K Buy
+93
New +$41.9K ﹤0.01% 2379
2019
Q2 		– Sell
-41
Closed -$87K – 3275
2019
Q1 		$87K Buy
41
+22
+116% +$65.5K ﹤0.01% 2908
2018
Q4 		$60K Buy
+19
New +$30.4K ﹤0.01% 2855

Other funds holding ADIL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MCM
Manchester Capital Management Manchester, Vermont $694M AUM 22.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Two Sigma Investments's ADIL Position: Q3 2025 in Review

Two Sigma Investments sold out of Adial Pharmaceuticals (ADIL) in Q3 2025, closing a stake of 432 shares — an estimated $3.26K sold.

Two Sigma Investments first reported a position in ADIL in Q4 2018 and held it in 7 quarters. The position peaked at $87K in Q1 2019. 15 funds tracked by Wall St. Rank hold ADIL as of Q3 2025.

  • Two Sigma Investments reported no remaining Adial Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Investments sold 432 Adial Pharmaceuticals shares in Q3 2025, an estimated $3.26K.
  • Two Sigma Investments first reported a position in Adial Pharmaceuticals in Q4 2018 and held it in 7 quarters.
  • Two Sigma Investments's Adial Pharmaceuticals position peaked at $87K in Q1 2019.
  • 15 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q3 2025.

Based on Two Sigma Investments's 13F filing for Q3 2025, filed 14 Nov 2025.